Empagliflozin reduced proinflammatory cytokines and oxidative stress markers in INOCA patients with CMD, improving vascular health. Treatment led to favorable shifts in endothelial extracellular ...
A recent study published in the journal Nature showed that the dysregulation of the brain endothelial glycocalyx layer impairs the blood-brain barrier (BBB) in disease and aging. The BBB forms a ...
It is well known that type 2 diabetes raises the risk of heart attack and stroke and that risk tends to increase over time. A new study from Karolinska Institutet suggests one possible reason may sit ...
After years of type 2 diabetes, red blood cells may quietly turn against the heart—offering a new clue for spotting danger early. People who live with type 2 diabetes for many years face a steadily ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results